Description

Spegra (Dolutegravir/Emtricitabine/Tenofovir Alafenamide) – Prescription Antiretroviral Medicine for HIV-1 Treatment

Spegra is a prescription antiretroviral medicine formulated with Dolutegravir, Emtricitabine, and Tenofovir Alafenamide (TAF), a combination of antiviral medicines used for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection in adults and eligible adolescents. This fixed-dose combination works by blocking different stages of the HIV replication cycle. Dolutegravir inhibits the HIV integrase enzyme, while Emtricitabine and Tenofovir Alafenamide inhibit the reverse transcriptase enzyme, helping reduce viral replication and lower the amount of HIV in the body.

Spegra helps achieve and maintain viral suppression, supports immune system function, and reduces the risk of HIV-related complications when taken consistently as prescribed. It does not cure HIV infection and should only be used under the supervision of a qualified healthcare professional as part of an appropriate HIV treatment plan.

The medicine is prescribed after careful medical evaluation, as treatment suitability depends on factors including previous antiretroviral therapy, viral resistance profile, kidney function, liver function, and overall health condition.

• Key Features

1. Contains Dolutegravir, Emtricitabine, and Tenofovir Alafenamide
2. Prescription-only antiretroviral medication
3. Complete once-daily oral HIV treatment regimen
4. Combines an Integrase Strand Transfer Inhibitor (INSTI) with two NRTIs
5. Helps suppress HIV-1 viral replication
6. Supports long-term management of HIV infection
7. Manufactured under quality pharmaceutical standards

How to Take Spegra

For the best therapeutic outcome, take Spegra exactly as directed by your healthcare provider. It is generally taken once daily, with or without food. Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless instructed by your physician.

Take the medicine at the same time every day to help maintain consistent drug levels. Do not skip doses or discontinue treatment without medical advice, as this may lead to viral resistance and treatment failure.

• General Dosage Reference

Medical Condition	Recommended Adult Dose
HIV-1 Infection	One tablet once daily
Long-term HIV Management	Continue as prescribed by the healthcare provider
Renal or Hepatic Impairment	Dose suitability determined by the treating physician

The exact dosage should always be determined by your healthcare provider based on your medical history, kidney and liver function, concomitant medications, and current HIV treatment guidelines.

Safety Information

Before starting Spegra, inform your healthcare provider if you have kidney disease, liver disease, hepatitis B infection, osteoporosis, or any known allergy to Dolutegravir, Emtricitabine, Tenofovir Alafenamide, or any ingredients in the medicine.

Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before starting treatment. Inform your physician about all prescription medicines, over-the-counter drugs, vitamins, and herbal supplements, as certain medicines may interact with Spegra.

Most patients tolerate Spegra well when taken as prescribed. Some individuals may experience mild side effects such as headache, nausea, diarrhea, dizziness, fatigue, insomnia, or abdominal discomfort. Seek immediate medical attention if you develop symptoms of a severe allergic reaction, liver problems, lactic acidosis, significant kidney-related symptoms, or severe skin reactions.

Patients with hepatitis B infection should not discontinue treatment without medical supervision because stopping medicines containing Emtricitabine or Tenofovir Alafenamide may lead to severe worsening of hepatitis B.

Product Specifications

Specification	Information
Brand	Spegra
Generic Name	Dolutegravir / Emtricitabine / Tenofovir Alafenamide
Active Ingredients	Dolutegravir + Emtricitabine + Tenofovir Alafenamide
Strength	As Prescribed
Dosage Form	Oral Tablet
Drug Class	Antiretroviral (INSTI + NRTI Combination)
Route of Administration	Oral
Prescription Status	Prescription Required
Storage	Store below 30°C in a cool, dry place away from moisture and direct sunlight

Frequently Asked Questions

Can Spegra be taken with food?

Yes. Spegra may generally be taken with or without food unless your healthcare provider advises otherwise.

Is Spegra a cure for HIV?

No. Spegra does not cure HIV infection. It helps control viral replication and maintain viral suppression when taken consistently as prescribed.

Can Spegra be used alone?

Yes. Spegra is a complete fixed-dose antiretroviral combination designed for use as a full HIV treatment regimen when prescribed by a healthcare professional.

How long should Spegra be taken?

HIV treatment is generally lifelong. Continue taking Spegra exactly as prescribed and attend regular medical follow-up appointments to monitor treatment effectiveness.

What should I do if I miss a dose?

Take the missed dose as soon as you remember unless it is almost time for your next scheduled dose. Do not take two doses together. If you are unsure, consult your healthcare provider.